On this page
Dabigatran Etexilate
DABIGATRAN ETEXILATE MESYLATE
Active ingredient 5 prescription 18 with labelling
Overview
Source: NDC DirectoryIngredient name
DABIGATRAN ETEXILATE MESYLATE
Base moiety
DABIGATRAN ETEXILATE
RxNorm CUI
UNII
SC7NUW5IIT
Medication products
6
Brand names
3
Dosage forms
4
FAERS reports
72,208 · not a risk measure
- Dabigatran Etexilate Mesylate Powder
- DABIGATRAN Dabigatran Etexilate · Capsule
- Dabigatran Etexilate Capsule
- Dabigatran Etexilate Capsule, Coated Pellets
- Pradaxa dabigatran etexilate · Pellet
- Pradaxa dabigatran etexilate mesylate · Capsule
Entries without a link are products listed by the FDA that carry no approval record, therapeutic equivalence rating or official labelling, so they have no detail page. Their facts are shown inline.
By dosage form
| Dosage form | Products | Examples |
|---|---|---|
| Capsule | 3 | DABIGATRAN, Dabigatran Etexilate, Pradaxa |
| Powder | 1 | Dabigatran Etexilate Mesylate |
| CAPSULE, Coated Pellets | 1 | Dabigatran Etexilate |
| Pellet | 1 | Pradaxa |
Sources for this page
| Dataset | Agency | Used for |
|---|---|---|
| NDC Directory | FDA | Ingredient name, strengths, products, labelers, packages |
| DailyMed RxNorm mappings | NLM | RxNorm concept identifier (RxCUI) |
| FAERS | FDA | Adverse event report totals |